These data not only gave us potential leads to follow, but also led us to the conclusion that while CLD uniformly induces the expansion of lymphatic vessels in the liver, NASH-associated liver disease elicited a unique transcriptional profile in liver LECs that involves IL13 signaling. Here, IL13 is linked to metabolic dysfunction-associated steatohepatitis.